Evidence map›Paper›PMID 31311312›Full record

ArticleJournal of diabetes science and technology2021

Clinical Evaluation of a New, Lower Pain, One Touch Lancing Device for People With Diabetes: Virtually Pain-Free Testing and Improved Comfort Compared to Current Lancing Systems.

Mike Grady, Greg Lamps, Ashley Shemain, Hilary Cameron, Linda Murray

Open access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Unleashing the Potential of Blood Glucose Monitoring Data With the Ambulatory Glucose Profile Report.Clinical diabetes : a publication of the American Diabetes Association · 2024
    Article
  6. Effect of low-frequency blood glucose self-monitoring on glycosylated hemoglobin levels among older adults with type 2 diabetes mellitus.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024
    Article
  7. Sustained Improvements in Readings in-Range Using an Advanced BluetoothDiabetes therapy : research, treatment and education of diabetes and related disorders · 2023
    Article
  8. Review
  9. Article
  10. Reliability of continuous glucose monitoring system in the inpatient setting.Journal of clinical & translational endocrinology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mike GradyLifeScan Scotland Ltd., Inverness, UK.ORCID 0000-0002-8006-1844
Greg LampsAPS America, LLC., Marietta, GA, USA.ORCID 0000-0001-6312-9723
Ashley ShemainAPS America, LLC., Marietta, GA, USA.
Hilary CameronLifeScan Scotland Ltd., Inverness, UK.
Linda MurraySynexus USA, Pinellas Park, FL, USA.
Synexus (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients worldwide use lancing devices to perform self-monitoring of blood glucose (SMBG). Continued innovation remains important to minimize pain associated with finger sticking to facilitate patient adherence to SMBG regimens. The original One Touch Delica lancer (OTD) reduced the pain of testing. This study investigated a completely re-engineered lancing system, called One Touch Delica Plus (OTDP), intended to further minimize pain while improving the patient experience.

methodsOne hundred and three subjects (type 1 or 2 diabetes) experienced finger sticks with both lancing systems. Device depth and blood volume (BV) generation were determined during visit 1. These parameters were used during pain assessments in visit 2. Patient feedback was also recorded using surveys.

resultsFinger-stick testing was less painful using OTDP compared to original OTD irrespective of whether 30 (-48.2 mm, -30.4 mm,

conclusionOTDP demonstrated lower pain than the original OTD lancing system and participants agreed that testing with OTDP was virtually pain free and less painful than using their current lancing systems.

Indexed as

Blood Glucose Self-MonitoringDiabetes MellitusBlood Specimen CollectionHumansPainPain Measurementblood samplingglucose monitoringlancetslancing devicepain

Identifiers

PMID31311312
PMCPMC7783011
OpenAlexW2960188884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.